Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Spontaneous Urticaria”

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06445023
What this trial is testing

Barzolvolimab in Participants With Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous Urticaria
Celldex Therapeutics 963
Testing effectiveness (Phase 2)Ended earlyNCT05528861
What this trial is testing

Assess Subcutaneous Lirentelimab (AK002) in Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous Urticaria
Allakos Inc. 127
Early research (Phase 1)Active Not RecruitingNCT06604949
What this trial is testing

Single Dose of LP-003 in Healthy Adult Subjects

Who this might be right for
Chronic Spontaneous Urticaria
Longbio Pharma 12
Testing effectiveness (Phase 2)Study completedNCT04833855
What this trial is testing

Study to Evaluate Tezepelumab in Adults With Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous Urticaria
Amgen 183
Testing effectiveness (Phase 2)Study completedNCT01599637
What this trial is testing

Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine Treatment

Who this might be right for
Chronic Idiopathic Urticaria
Novartis Pharmaceuticals 40
Large-scale testing (Phase 3)Ended earlyNCT04210843
What this trial is testing

Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 1,033
Large-scale testing (Phase 3)Not Yet RecruitingNCT07816328
What this trial is testing

Investigation of a Remibrutinib- and Omalizumab-based Treatment Algorithm in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1-antihistamines Within 24 Weeks

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 382
Testing effectiveness (Phase 2)Study completedNCT06873516
What this trial is testing

Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)

Who this might be right for
Chronic Spontaneous Urticaria
Evommune, Inc. 182
Large-scale testing (Phase 3)Study completedNCT05795153
What this trial is testing

A Multicenter, Open-label Phase 3 Study: Ambulatory Blood Pressure Monitoring in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1-antihistamines Treated With Remibrutinib up to 12 Weeks.

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 144
Large-scale testing (Phase 3)Ended earlyNCT02358265
What this trial is testing

Chronic Urticaria - Long Term Assessment of Effects of Rupatadine

Who this might be right for
Chronic Urticaria
Charite University, Berlin, Germany 192
Not applicableStudy completedNCT00724698
What this trial is testing

Evaluation of Desloratadine When Used in Patients With Either Allergic Rhinitis or Chronic Idiopathic Urticaria

Who this might be right for
RhinitisUrticaria
Organon and Co 3,011
Early research (Phase 1)Study completedNCT02424799
What this trial is testing

Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264

Who this might be right for
Urticaria
GlaxoSmithKline 34
Early research (Phase 1)Study completedNCT06294288
What this trial is testing

Single and Multiple Doses of LP-003 in Healthy Adult Participants

Who this might be right for
Chronic Spontaneous Urticaria
Longbio Pharma 60
Large-scale testing (Phase 3)Study completedNCT00421109
What this trial is testing

Efficacy Study for the Symptomatic Treatment of Chronic Idiopathic Urticaria

Who this might be right for
Urticaria
Faes Farma, S.A. 522
Testing effectiveness (Phase 2)WithdrawnNCT06795373
What this trial is testing

Ritlecitinib (PF-06651600) in Participants With Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous UrticariaCSU
Ahuva D Cices
Testing effectiveness (Phase 2)Looking for participantsNCT07166211
What this trial is testing

Study of CM512 Injection in Subjects With Chronic Spontaneous Urticaria(CSU)

Who this might be right for
Chronic Spontaneous Urticaria (CSU)
Keymed Biosciences Co.Ltd 48
Not applicableEnded earlyNCT07316114
What this trial is testing

Describe the Real-world Effectiveness, Safety and Patterns of Use of Dupilumab in Patients With Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous Urticaria
Sanofi 1
Post-approval studies (Phase 4)Study completedNCT02550106
What this trial is testing

Omalizumab in Chronic Spontaneous Urticaria Patients Non Responding to Initial Standard antihistaminE Treatment

Who this might be right for
CHRONIC SPONTANEOUS URTICARIA
Novartis Pharmaceuticals 136
Not applicableEnrolling By InvitationNCT07431658
What this trial is testing

Effects of Diet and Oxidative Stress on Disease Severity and Response to Omalizumab in Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous Urticaria (CSU)
Istanbul Training and Research Hospital 116
Not applicableAvailableNCT05170724
What this trial is testing

Global Managed Access Program Cohort for Remibrutinib in Adult Patients With Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation